Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Publication year range
1.
AJNR Am J Neuroradiol ; 43(12): 1802-1809, 2022 12.
Article in English | MEDLINE | ID: mdl-36328408

ABSTRACT

Nelarabine is a nucleoside analog critical for the treatment of patients with T-cell acute lymphoblastic leukemia/lymphoma. However, clinical peripheral and central neurologic adverse events associated with nelarabine administration have been reported. Neuroimaging of brain neurotoxicity has only been described in very few reports in pediatric patients so far. Six children with diagnosed T-cell acute lymphoblastic leukemia who clinically experienced possible, probable, or definite nelarabine-induced toxicity and underwent spine and/or brain MR imaging were reviewed. Neuroimaging findings showed a mixture of patterns including features of acute toxic leukoencephalopathy (seen in 6 cases), posterior reversible encephalopathy syndrome (2 cases), involvement of deep gray structures (1 case) and brainstem (2 cases), cranial and spinal neuropathy (2 cases each), and myelopathy (2 cases). Even though neuroimaging findings are nonspecific, the goal of this article was to alert the pediatric neuroradiologists, radiologists, and clinicians about the possibility of nelarabine-induced neurotoxicity and its broad neuroimaging spectrum.


Subject(s)
Posterior Leukoencephalopathy Syndrome , Precursor Cell Lymphoblastic Leukemia-Lymphoma , Spinal Cord Diseases , Humans , Child , Arabinonucleosides/adverse effects , Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy
2.
AJNR Am J Neuroradiol ; 43(11): 1667-1673, 2022 11.
Article in English | MEDLINE | ID: mdl-36265894

ABSTRACT

BACKGROUND AND PURPOSE: Juvenile xanthogranuloma is a rare clonal, myeloid, neoplastic disorder. Typically, juvenile xanthogranuloma is a self-limited disorder of infancy, often presenting as a solitary red-brown or yellow skin papule/nodule. A small subset of patients present with extracutaneous, systemic juvenile xanthogranuloma, which may include the CNS. The goal of this retrospective study was to evaluate and categorize the neuroimaging findings in a representative cohort of pediatric patients with CNS juvenile xanthogranuloma. MATERIALS AND METHODS: The brain and/or spine MR imaging data of 14 pediatric patients with pathology-proven juvenile xanthogranuloma were categorized and evaluated for the location; the signal intensity of xanthogranulomas on T1WI, T2WI, DWI, and a matching ADC map for the pattern and degree of contrast enhancement; and the presence of perilesional edema, cysts, or necrosis. RESULTS: Fourteen pediatric patients (8 girls, 6 boys; mean age, 84 months) were included in the study. Patients presented with a wide variety of different symptoms, including headache, seizure, ataxia, strabismus, hearing loss, facial paresis, and diabetes insipidus. Juvenile xanthogranuloma lesions were identified in a number of different sites, including supra- and infratentorial as well as intracranial and spinal leptomeningeal. Five patients were categorized into the neuroradiologic pattern unifocal CNS juvenile xanthogranuloma; 8, into multifocal CNS juvenile xanthogranuloma; and 1, into multifocal CNS juvenile xanthogranuloma with intracranial and spinal leptomeningeal disease. In most cases, xanthogranulomas were small-to-medium intra-axial masses with isointense signal on T1WI (compared with cortical GM), iso- or hyperintense signal on T2WI, had restricted diffusion and perilesional edema. Almost all xanthogranulomas showed avid contrast enhancement. However, we also identified less common patterns with large lesions, nonenhancing lesions, or leptomeningeal disease. Four cases had an additional CT available. On CT, all xanthogranulomas were homogeneously hyperdense (solid component) without evident calcifications. CONCLUSIONS: CNS juvenile xanthogranuloma may demonstrate heterogeneous neuroimaging appearances potentially mimicking other diseases, such as primary brain neoplasms, metastatic disease, lymphoma and leukemia, other histiocytic disorders, infections, or granulomatous diseases.


Subject(s)
Xanthogranuloma, Juvenile , Male , Female , Child , Humans , Xanthogranuloma, Juvenile/diagnostic imaging , Retrospective Studies , Magnetic Resonance Imaging , Neuroimaging , Head/pathology
3.
Can J Microbiol ; 59(6): 437-41, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23750960

ABSTRACT

The presence of subtilase-cytotoxin-encoding genes was determined in 397 environmental Escherichia coli strains isolated from water, suspended solids, and sediments sampled from different hydrological and environmental conditions in a California estuary. A total of 7 strains (1.76%) were found to harbor subtilase-cytotoxin-encoding genes. Using primers targeting subA only, we generated PCR amplicons from 2 strains; while using primers targeting the 3' end of SubA downstream to the 5' end of SubB, amplicons of 232 bp were generated from 5 additional strains. The 556 bp subA sequences were almost identical to that in the subtilase-cytotoxin-positive strain ED 591 (98%), while subAB sequences of 2 non-Shiga-toxigenic strains revealed 100% similarity with the Shiga-toxigenic E. coli O113:H21 strain 98NK2 that was isolated from an outbreak of hemolytic uremic syndrome. Additionally, the serogroup O113:H21 was present in this collection of environmental E. coli, and it was found to harbor stx2d, hra1 that encodes the heat resistant agglutinin 1, and a subAB sequence similar to that in the non-Shiga-toxigenic E. coli subtilase cytotoxin strain ED 591. To further understand potential health risks posed by strains encoding SubAB, future epidemiological studies should consider screening isolates for subAB regardless of the presence of Shiga-toxin-encoding genes.


Subject(s)
Escherichia coli Proteins/genetics , Escherichia coli/genetics , Escherichia coli/isolation & purification , Estuaries , Subtilisins/genetics , Water Microbiology , Bacterial Outer Membrane Proteins/genetics , California , Cytotoxins/genetics , Escherichia coli/classification , Escherichia coli Infections/epidemiology , Genes, Bacterial , Geologic Sediments/microbiology , Polymerase Chain Reaction , Shiga Toxin/genetics , Virulence Factors/genetics
4.
Cell Adhes Commun ; 3(6): 497-509, 1996 Apr.
Article in English | MEDLINE | ID: mdl-8807193

ABSTRACT

The vertebrate neural cell adhesion molecule NCAM mediates heterophilic adhesion to heparan sulfate proteoglycans in embryonic chick brain membranes. In this study, mouse L cells transfected with chicken NCAM were used to identify two of these ligands as agrin and the target of the 6C4 monoclonal antibody. A third heparan sulfate proteoglycan, perlecan, appeared not to support NCAM-mediated adhesion. Enzymatic degradation of chondroitin sulfates decreased adhesion in agrin-containing membrane fractions but increased adhesion if the agrin had previously been removed by immunoprecipitation, suggesting that interactions between heparan sulfate and chondroitin sulfate proteoglycans have important influences on adhesion. Our experiments support the view that NCAM can interact with multiple, but not with all, heparan sulfate and chondroitin sulfate proteoglycans in chick brain membranes in both positive and negative ways to influence cell adhesion.


Subject(s)
Agrin/metabolism , Cell Adhesion/physiology , Heparan Sulfate Proteoglycans , Neural Cell Adhesion Molecules/physiology , Agrin/isolation & purification , Animals , Antibodies, Monoclonal , Brain Chemistry , Cell Adhesion/drug effects , Cell Extracts , Cell Membrane/chemistry , Chick Embryo , Chondroitin Lyases , Chondroitin Sulfates/metabolism , Heparin/pharmacology , Heparin Lyase , Heparitin Sulfate/metabolism , Heparitin Sulfate/pharmacology , L Cells , Ligands , Mice , Neural Cell Adhesion Molecules/genetics , Polysaccharide-Lyases , Proteoglycans/metabolism , Transfection
SELECTION OF CITATIONS
SEARCH DETAIL
...